Blood News and Research

RSS

QIAGEN's new QIAsafe DNA blood products launched

Biomatrica, Inc. and QIAGEN announce the launch of QIAGEN's new QIAsafe DNA Blood Products, the first dry blood storage available on a matrix based on Biomatrica's innovative SampleMatrix(R) technology.

From QIAGEN Manchester Limited 10 Sep 2009

New treatment strategies for multiple sclerosis

The drawback in the new immunotherapies in multiple sclerosis (MS) includMe severe infections that can be fatal. For example, treatment with natalizumab, which reduces the immune surveillance of the brain, can lead to the development of progressive multifocal leukoencephalopathy (PML), a typically fatal form of viral encephalitis.

10 Sep 2009

ThermoGenesis releases results for fourth quarter and fiscal year 2009

ThermoGenesis Corp. , a leading supplier of innovative products for processing and storing adult stem cells, today reported results for the fourth quarter and all of fiscal 2009.

10 Sep 2009

Non-invasive CR-2000 Research System to be used in START clinical trial

Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.

10 Sep 2009

U.S patent for Tryton Side Branch Stent System

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company’s Tryton Side Branch Stent™ System.

10 Sep 2009

New form of malarial infection identified

Researchers in Malaysia have identified key laboratory and clinical features of an emerging new form of malaria infection. The research, funded by the Wellcome Trust, confirms the potentially deadly nature of the disease.

10 Sep 2009

Varying physical activity for optimal health benefits

How hard and for how long should you exercise in order to shed excess abdominal fat and reduce your risk of cardiovascular disease?

10 Sep 2009

Researchers find link between traffic noise and increased blood pressure

Traffic noise raises blood pressure. Researchers writing in BioMed Central's open access journal Environmental Health have found that people exposed to high levels of noise from nearby roads are more likely to report suffering from hypertension.

10 Sep 2009

Oral GLP-1 Analog approved for human clinical trial

Oramed Pharmaceticals, Inc., a developer of oral drug delivery systems, announced today that it has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog.

10 Sep 2009

Lead exposure may result in cardiovascular mortality

Growing evidence shows that exposure to lead in the environment is associated with cardiovascular disease, including increased risk of hypertension. However, those studies have looked at lead concentrations in blood, not bone lead, a better indicator of cumulative lead exposure over time.

10 Sep 2009

Risk of NAFLD lowers with routine physical activities

Researchers from the University of Sydney, Australia determined that patients with a sedentary lifestyle who engage in routine physical activities lower their risk of nonalcoholic fatty liver disease (NAFLD).

10 Sep 2009

OSI Systems signs partnership agreement with Irish software firm, dabl

OSI Systems, Inc. (NASDAQ:OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has entered into an agreement with Irish software firm, dabl® Ltd.

10 Sep 2009

Free, online self-assessment quiz helps assess health and lifestyle risks for PAD

As recent medical studies continue to highlight the seriousness of peripheral arterial disease (or PAD) and its association with heart attack, stroke and early mortality, the Society of Interventional Radiology Foundation recommends that older Americans, smokers and diabetics take its free, online self-assessment quiz.

10 Sep 2009

Genomic technologies to improve wine production techniques

While the art of fine winemaking is a beautiful thing, winemakers are increasingly turning to the power of science to give them the tools they need to ensure a high quality pour each and every time.

10 Sep 2009

First trial of 2009 H1N1 influenza vaccine testing launched

The first trial testing a candidate 2009 H1N1 influenza vaccine in pregnant women is launching this week, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today.

10 Sep 2009

Society of Interventional Radiology's resources emphasize on PAD

The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.

10 Sep 2009

Obesity experts call on policymakers to adopt obesity recommendations

The Obesity Society and other steering committee members of the Strategies to Overcome and Prevent (STOP) Obesity Alliance, and two former US Surgeons General, join together today to develop effective recommendations to urge policymakers to act on the inclusion of obesity as the largest and most urgent driving factor in healthcare reform.

10 Sep 2009

University of California receives $3.5 million grant from NIDA for AIDS vaccine research

The National Institute on Drug Abuse (NIDA) has awarded a $3.5 million grant for AIDS vaccine research to Phillip Berman, professor and chair of biomolecular engineering at the Jack Baskin School of Engineering at the University of California, Santa Cruz.

9 Sep 2009

Medpro completes preliminary testing and regulatory requirements for its VACUETTE safety needle system

MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development and marketing of passive needlestick injury prevention technology, announced today it has completed preliminary testing and regulatory requirements for the VACUETTE® PREMIUM Safety Needle System Tube-Touch model, a single-patient, multiple sample blood collection safety needle system.

9 Sep 2009

VIVUS' Phase 3 studies find Qnexa effective in tackling obesity

VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.

9 Sep 2009